| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1471-4914(02)02394-8 |
| P698 | PubMed publication ID | 12383771 |
| P50 | author | Patrick Auguste | Q57323571 |
| Andreas Bikfalvi | Q88597327 | ||
| P2093 | author name string | Sophie Javerzat | |
| P2860 | cites work | Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization | Q24290400 |
| Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress | Q24291389 | ||
| Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis | Q24291956 | ||
| Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2 | Q24313613 | ||
| Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins | Q24629903 | ||
| Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals | Q24654177 | ||
| Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis | Q28577598 | ||
| Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C | Q28589290 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina | Q30903366 | ||
| Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts | Q31939873 | ||
| Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. | Q33787009 | ||
| Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. | Q34066152 | ||
| Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein | Q34087175 | ||
| Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis | Q34110003 | ||
| The role of FGF and VEGF in angioblast induction and migration during vascular development | Q34123470 | ||
| A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. | Q34442731 | ||
| Gene transfer to induce angiogenesis in myocardial and limb ischaemia | Q34452694 | ||
| Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development | Q36064260 | ||
| Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. | Q36235250 | ||
| Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis | Q36256017 | ||
| Fibroblast growth factor-specific modulation of cellular response by syndecan-4 | Q36325233 | ||
| Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb | Q37376876 | ||
| Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial | Q38523342 | ||
| Role of c-Fyn in FGF-2-mediated tube-like structure formation by murine brain capillary endothelial cells | Q40754663 | ||
| Signals via FGF receptor 2 regulate migration of endothelial cells | Q40764999 | ||
| Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. | Q40792578 | ||
| Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia | Q40810334 | ||
| The nonreceptor protein-tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells | Q40890115 | ||
| Semirational design of a potent, artificial agonist of fibroblast growth factor receptors | Q40913538 | ||
| Biological roles of fibroblast growth factor-2. | Q41349632 | ||
| Oxygen regulation of airway branching in Drosophila is mediated by branchless FGF. | Q41698275 | ||
| Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor | Q41752994 | ||
| p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis | Q42134844 | ||
| Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression | Q42794629 | ||
| The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase | Q43695716 | ||
| Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. | Q45884809 | ||
| Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. | Q52129710 | ||
| Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. | Q52166285 | ||
| Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells. | Q52541029 | ||
| Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. | Q53900090 | ||
| FIF [Fibroblast Growth Factor-2 (FGF-2)-Interacting-Factor], a Nuclear Putatively Antiapoptotic Factor, Interacts Specifically with FGF-2 | Q56602275 | ||
| Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro | Q67466166 | ||
| Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor | Q67542808 | ||
| Murine FGFR-1 is required for early postimplantation growth and axial organization | Q71989885 | ||
| Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease | Q73030654 | ||
| Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia | Q73392873 | ||
| Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation | Q73441800 | ||
| Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth | Q73585686 | ||
| A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2 | Q73644214 | ||
| Angiogenesis in ischemic human myocardium: clinical results after 3 years | Q73957780 | ||
| Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis | Q77347327 | ||
| Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate | Q77359737 | ||
| FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice | Q77871892 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 483-489 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Trends in Molecular Medicine | Q15265842 |
| P1476 | title | The role of fibroblast growth factors in vascular development | |
| P478 | volume | 8 |
| Q63406959 | A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing |
| Q37640001 | A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma |
| Q36502806 | Aberrant expression of hSef and Sprouty4 in endometrial adenocarcinoma |
| Q35659739 | Acidic Fibroblast Growth Factor Promotes Endothelial Progenitor Cells Function via Akt/FOXO3a Pathway |
| Q37645436 | Angiogenesis in the atherosclerotic plaque. |
| Q26775947 | Anti-angiogenic alternatives to VEGF blockade |
| Q28535457 | Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis |
| Q36804518 | Antiangiogenic therapies for advanced hepatocellular carcinoma |
| Q36591067 | Antiangiogenic therapy in human gastrointestinal malignancies |
| Q27026936 | Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis |
| Q42012051 | Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. |
| Q40989712 | Changes in expression of proteoglycan core proteins and heparan sulfate enzymes in the developing and adult murine aorta |
| Q37094042 | Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients |
| Q40171674 | Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. |
| Q35162409 | Controlled protein delivery in the generation of microvascular networks. |
| Q34317591 | Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography |
| Q41900600 | Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo |
| Q33947958 | Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway |
| Q36699574 | Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury |
| Q33194984 | Evolving revascularization approaches for myocardial ischemia |
| Q41466827 | Expression of pro- and anti-angiogenic factors during the formation of the periocular vasculature and development of the avian cornea |
| Q92882076 | Extracellular Vesicles Derived from Human Gingival Mesenchymal Stem Cells: A Transcriptomic Analysis |
| Q33363570 | FGF2 translationally induced by hypoxia is involved in negative and positive feedback loops with HIF-1alpha. |
| Q40807184 | FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network |
| Q42802160 | Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation |
| Q42108907 | Fibroblast Growth Factor-1 vs. Fibroblast Growth Factor-2 in Ischemic Skin Flap Survival in a Rat Animal Model |
| Q40248796 | Fibroblast growth factor-2 induces the activation of Src through Fes, which regulates focal adhesion disassembly |
| Q34756222 | Fibroblast growth factor-2 promotes in vitro mitral valve interstitial cell repair through transforming growth factor-β/Smad signaling |
| Q40617929 | Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt |
| Q34591107 | Fibroblast growth factors: biology, function, and application for tissue regeneration |
| Q81189165 | Functional recovery of chronic complete idiopathic transverse myelitis after administration of neurotrophic factors |
| Q35141791 | Gene transfer as a tool to induce therapeutic vascular growth |
| Q35937557 | Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia |
| Q54648821 | Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1 |
| Q24681517 | Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation |
| Q89304559 | IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers |
| Q40620317 | Inactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeleton |
| Q92705359 | Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors |
| Q36159811 | Investigation of the biological properties of Cinnulin PF in the context of diabetes: mechanistic insights by genome-wide mRNA-Seq analysis |
| Q38832513 | Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma |
| Q57817458 | Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 |
| Q44453748 | MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb |
| Q34807068 | Mesothelium of the murine allantois exhibits distinct regional properties |
| Q43715916 | MiR-1 and miR-206 target different genes to have opposing roles during angiogenesis in zebrafish embryos |
| Q45168511 | Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer. |
| Q28079232 | Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies |
| Q33981022 | Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways |
| Q37503510 | Neuronal control of metabolism through nutrient-dependent modulation of tracheal branching |
| Q36954201 | Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release |
| Q81004145 | Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis |
| Q84218027 | Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells |
| Q48140644 | Pathogenesis of peri-tumoral edema in intracranial meningiomas. |
| Q34273411 | Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics |
| Q44729061 | Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. |
| Q43241422 | Prefabrication of vascularized bone graft using an interconnected porous calcium hydroxyapatite ceramic in presence of vascular endothelial growth factor and bone marrow mesenchymal stem cells: Experimental study in rats |
| Q28587821 | Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis |
| Q35590787 | RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR. |
| Q36138934 | Radiation-Triggered NF-κB Activation is Responsible for the Angiogenic Signaling Pathway and Neovascularization for Breast Cancer Cell Proliferation and Growth |
| Q40620288 | Regulation of endothelial cell differentiation and transformation by H-Ras |
| Q41494887 | Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies |
| Q53285931 | Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway. |
| Q37728308 | Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. |
| Q55472739 | Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. |
| Q34333133 | Study of the association of adrenomedullin and basic-fibroblast growth factors with the peripheral arterial blood flow and endothelial dysfunction biomarkers in type 2 diabetic patients with peripheral vascular insufficiency |
| Q38498207 | Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor |
| Q37062121 | Targeting angiogenesis in pancreatic cancer: rationale and pitfalls |
| Q24339432 | The F-BAR protein NOSTRIN participates in FGF signal transduction and vascular development. |
| Q33275125 | The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival |
| Q34812110 | The cytokines within the carotid plaque in symptomatic patients with internal carotid artery stenosis. |
| Q36598516 | The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors |
| Q36390431 | The role of VEGF receptors in angiogenesis; complex partnerships |
| Q37512303 | The role of fibroblast growth factors in tumor growth |
| Q42129574 | Topical bFGF Improves Secondary Lymphedema through Lymphangiogenesis in a Rat Tail Model |
| Q37978317 | Vascular complications and diabetes: current therapies and future challenges |
| Q35238403 | WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1 |
| Q100385947 | bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice |
| Q59342737 | bFGF interaction and in vivo angiogenesis inhibition by self-assembling sulfonic acid-based copolymers |
Search more.